CoChat
Sign Up
Cited by 587

The DOI matches its Crossref record.

CD5 Expression Is Developmentally Regulated By T Cell Receptor (TCR) Signals and TCR Avidity

Azzam, Hala S., Grinberg, Alex, Lui, Kin, Shen, Howard, Shores, Elizabeth W., Love, Paul E.·1998·The Journal of Experimental Medicine
DOI 10.1084/jem.188.12.2301PMC PMC2212429
Open this paper in CoChat — free account

Abstract

Recent data indicate that the cell surface glycoprotein CD5 functions as a negative regulator of T cell receptor (TCR)-mediated signaling. In this study, we examined the regulation of CD5 surface expression during normal thymocyte ontogeny and in mice with developmental and/or signal transduction defects. The results demonstrate that low level expression of CD5 on CD4−CD8− (double negative, DN) thymocytes is independent of TCR gene rearrangement; however, induction of CD5 surface expression on DN thymocytes requires engagement of the pre-TCR and is dependent upon the activity of p56lck. At the CD4+CD8+ (double positive, DP) stage, intermediate CD5 levels are maintained by low affinity TCR–major histocompatibility complex (MHC) interactions, and CD5 surface expression is proportional to both the surface level and signaling capacity of the TCR. High-level expression of CD5 on DP and CD4+ or CD8+ (single positive, SP) thymocytes is induced by engagement of the α/β-TCR by (positively or negatively) selecting ligands. Significantly, CD5 surface expression on mature SP thymocytes and T cells was found to directly parallel the avidity or signaling intensity of the positively selecting TCR–MHC-ligand interaction. Taken together, these observations suggest that the developmental regulation of CD5 in response to TCR signaling and TCR avidity represents a mechanism for fine tuning of the TCR signaling response.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1084/jem.188.12.2301

Cites

Statistics

Figures

Figure 1 CD5 expression during normal T cell development. (A) Thymus. (B) Lymph node. Thymocytes and T cells from a C57 BL/6 mouse were stained with CD5, CD4, and CD8, and CD5 was assessed by gating on the various populations. Histograms represent CD5 expression on the indicated subpopulations. Dotted lines represent staining with control (nonspecific) antibody.
Figure 1 CD5 expression during normal T cell development. (A) Thymus. (B) Lymph node. Thymocytes and T cells from a C57 BL/6 mouse were stained with CD5, CD4, and CD8, and CD5 was assessed by gating on the various populations. Histograms represent CD5 expression on the indicated subpopulations. Dotted lines represent staining with control (nonspecific) antibody.CC BY-NC-SA · PubMed Central
Figure 2 CD5 surface expression on thymocytes from Rag-2−/− and TCR-α−/− mice. Dot plots illustrate the CD4/CD8 staining profile and demonstrate the stage at which thymocyte development is blocked. Histograms depict CD5 and CD3 surface levels on gated CD4−CD8− (DN) thymocytes (A), or CD4+CD8+ (DP) thymocytes (B). CD5 and CD3 surface expression on DN and DP thymocytes from control (WT) animals are included for comparison. Dotted lines represent control peaks.
Figure 2 CD5 surface expression on thymocytes from Rag-2−/− and TCR-α−/− mice. Dot plots illustrate the CD4/CD8 staining profile and demonstrate the stage at which thymocyte development is blocked. Histograms depict CD5 and CD3 surface levels on gated CD4−CD8− (DN) thymocytes (A), or CD4+CD8+ (DP) thymocytes (B). CD5 and CD3 surface expression on DN and DP thymocytes from control (WT) animals are included for comparison. Dotted lines represent control peaks.CC BY-NC-SA · PubMed Central
Figure 3 (A) CD5 surface expression on CD4−CD8− (DN) thymocyte subsets. DN thymocytes from B6 mice were isolated as described in Materials and Methods, and stained with CD25 and CD44 antibodies to distinguish the various DN subpopulations (dot plot). Histogram on the left shows CD5 expression levels on gated CD44− CD25+ and CD44−CD25− thymocyte subpopulations. The middle histogram shows forward scatter profile of DN CD44− CD25+ thymocytes from B6 mice (white histogram) or from Rag-2−/− mice (gray histogram). Rag-2−/− thymocytes were used for placement of E and L gates as shown. Right histogram shows CD5 expression on E and L gated DN CD44−CD25+ thymocytes from B6 mice. (B) Induction of CD5 and CD69 surface expression on Rag-2−/− DN thymocytes by anti-CD3ε antibody. Left and middle: 200 μg of anti-CD3ε (2C11) antibody was injected into Rag-2−/− mice (+2C11) and CD5 (left) or CD69 (middle) surface levels on DN thymocytes were determined 24 h later. Control animals were injected with PBS (−2C11). Right: Rag-2−/− mice were injected with 0, 1, or 10 μg 2C11/gram body wt and DN thymocytes were analyzed for CD5 surface expression 3 d later. (C) CD5 surface expression on DN CD25+ and CD4+CD8+ (DP) thymocytes from lck−/− mice. CD5 levels on DN CD25+ and DP thymocytes from control (lck +/+) mice are included for comparison. (D) CD5 surface expression on gated CD4+CD8+ (DP) thymocytes from TCR-α−/− and TCR-α−/− × ζ−/− mice. Dotted lines represent staining with control antibody.
Figure 3 (A) CD5 surface expression on CD4−CD8− (DN) thymocyte subsets. DN thymocytes from B6 mice were isolated as described in Materials and Methods, and stained with CD25 and CD44 antibodies to distinguish the various DN subpopulations (dot plot). Histogram on the left shows CD5 expression levels on gated CD44− CD25+ and CD44−CD25− thymocyte subpopulations. The middle histogram shows forward scatter profile of DN CD44− CD25+ thymocytes from B6 mice (white histogram) or from Rag-2−/− mice (gray histogram). Rag-2−/− thymocytes were used for placement of E and L gates as shown. Right histogram shows CD5 expression on E and L gated DN CD44−CD25+ thymocytes from B6 mice. (B) Induction of CD5 and CD69 surface expression on Rag-2−/− DN thymocytes by anti-CD3ε antibody. Left and middle: 200 μg of anti-CD3ε (2C11) antibody was injected into Rag-2−/− mice (+2C11) and CD5 (left) or CD69 (middle) surface levels on DN thymocytes were determined 24 h later. Control animals were injected with PBS (−2C11). Right: Rag-2−/− mice were injected with 0, 1, or 10 μg 2C11/gram body wt and DN thymocytes were analyzed for CD5 surface expression 3 d later. (C) CD5 surface expression on DN CD25+ and CD4+CD8+ (DP) thymocytes from lck−/− mice. CD5 levels on DN CD25+ and DP thymocytes from control (lck +/+) mice are included for comparison. (D) CD5 surface expression on gated CD4+CD8+ (DP) thymocytes from TCR-α−/− and TCR-α−/− × ζ−/− mice. Dotted lines represent staining with control antibody.CC BY-NC-SA · PubMed Central
Figure 4 TCR levels and TCR signaling intensity influence CD5 expression on CD4+CD8+ (DP) thymocytes. (A) Effect of TCR levels on CD5 expression. Histograms depict CD5 and CD3 expression on gated CD4+CD8+ (DP) thymocytes from TCR-ζ heterozygotes (TCR-ζ+/−) and TCR-ζ-transgenic mice (TCR-ζ+/+; ζ tg) relative to control mice (TCR-ζ+/+). (B) Relationship between TCR signal intensity and CD5 expression. DP thymocytes were stimulated for 18 h on plates coated with the indicated amount of cross-linking antibody (anti-CD3ε; mAb 2C11) then analyzed for CD5 surface expression. (C) Effect of TCR signaling capacity on CD5 expression. Histograms depict CD5 and CD3 surface expression on DP thymocytes from TCR-ζ−/− mice reconstituted with transgenes encoding either full length ζ chain (ζ-3 ITAM) or ζ chain lacking sequences required for signal transduction (ζ-0 ITAM) (reference 30, see Results). Dotted lines represent staining with control antibody.
Figure 4 TCR levels and TCR signaling intensity influence CD5 expression on CD4+CD8+ (DP) thymocytes. (A) Effect of TCR levels on CD5 expression. Histograms depict CD5 and CD3 expression on gated CD4+CD8+ (DP) thymocytes from TCR-ζ heterozygotes (TCR-ζ+/−) and TCR-ζ-transgenic mice (TCR-ζ+/+; ζ tg) relative to control mice (TCR-ζ+/+). (B) Relationship between TCR signal intensity and CD5 expression. DP thymocytes were stimulated for 18 h on plates coated with the indicated amount of cross-linking antibody (anti-CD3ε; mAb 2C11) then analyzed for CD5 surface expression. (C) Effect of TCR signaling capacity on CD5 expression. Histograms depict CD5 and CD3 surface expression on DP thymocytes from TCR-ζ−/− mice reconstituted with transgenes encoding either full length ζ chain (ζ-3 ITAM) or ζ chain lacking sequences required for signal transduction (ζ-0 ITAM) (reference 30, see Results). Dotted lines represent staining with control antibody.CC BY-NC-SA · PubMed Central
Figure 5 CD5 surface expression on thymocytes from mice lacking MHC. (A) Histograms show CD5 and CD3 surface levels on gated CD4+CD8+ (DP) thymocyte populations from mice lacking expression of MHC class I (MHC I−/−) or MHC class I and class II [MHC (I × II−/−)]. CD3 and CD5 levels on DP thymocytes from control B6 (WT) mice are included for comparison. (B) CD5 levels on CD4−CD8− (DN) and DP thymocytes from MHC I−/− and MHC (I × II)−/− mice. (C) Induction of CD5 by CD3 cross-linking. Thymocytes from C56 BL/6 (WT) and MHC (I × II)−/− mice were incubated in the presence (+2C11) or absence (−2C11) of plate-bound anti-CD3ε antibody (50 μg) for 18 h at 37°C and CD5 and CD69 expression on DP thymocytes was assessed by FACS®. Dotted lines represent staining with control antibodies.
Figure 5 CD5 surface expression on thymocytes from mice lacking MHC. (A) Histograms show CD5 and CD3 surface levels on gated CD4+CD8+ (DP) thymocyte populations from mice lacking expression of MHC class I (MHC I−/−) or MHC class I and class II [MHC (I × II−/−)]. CD3 and CD5 levels on DP thymocytes from control B6 (WT) mice are included for comparison. (B) CD5 levels on CD4−CD8− (DN) and DP thymocytes from MHC I−/− and MHC (I × II)−/− mice. (C) Induction of CD5 by CD3 cross-linking. Thymocytes from C56 BL/6 (WT) and MHC (I × II)−/− mice were incubated in the presence (+2C11) or absence (−2C11) of plate-bound anti-CD3ε antibody (50 μg) for 18 h at 37°C and CD5 and CD69 expression on DP thymocytes was assessed by FACS®. Dotted lines represent staining with control antibodies.CC BY-NC-SA · PubMed Central
Figure 6 CD5 expression on thymocytes and mature T cells from TCR transgenic mice. (A) Comparison of CD5 levels on thymocytes and lymph node T cells from MHC class I–restricted (P14 H-2b and H-Y H-2b) TCR transgenic mice. (B) Comparison of CD5 levels on thymocytes and lymph node T cells from MHC class II–restricted (AND H-2bxk and DO10 H-2d) TCR transgenic mice. Single-color histograms represent CD5 staining on CD4+CD8+ thymocytes, as well as on CD8+ SP thymocytes and T cells (HY and P14 TCR transgenic mice), or CD4+ SP thymocytes and T cells (AND and DO10 TCR transgenic mice). Shown are CD5 levels on transgenic TCRhi gated cells. Data obtained for similar cell populations from nontransgenic (WT) mice are shown for comparison. Numbers in boxes depict mean CD5 fluorescence for the transgenic TCRhi cells.
Figure 6 CD5 expression on thymocytes and mature T cells from TCR transgenic mice. (A) Comparison of CD5 levels on thymocytes and lymph node T cells from MHC class I–restricted (P14 H-2b and H-Y H-2b) TCR transgenic mice. (B) Comparison of CD5 levels on thymocytes and lymph node T cells from MHC class II–restricted (AND H-2bxk and DO10 H-2d) TCR transgenic mice. Single-color histograms represent CD5 staining on CD4+CD8+ thymocytes, as well as on CD8+ SP thymocytes and T cells (HY and P14 TCR transgenic mice), or CD4+ SP thymocytes and T cells (AND and DO10 TCR transgenic mice). Shown are CD5 levels on transgenic TCRhi gated cells. Data obtained for similar cell populations from nontransgenic (WT) mice are shown for comparison. Numbers in boxes depict mean CD5 fluorescence for the transgenic TCRhi cells.CC BY-NC-SA · PubMed Central
Figure 7 (A) Comparison of CD5 levels on CD4+ thymocytes and T cells from DO10 TCR transgenic mice generated in the H-2dxd and H-2bxd backgrounds. Top: Two-color (CD4 versus CD8) analysis of thymocytes from DO10/H-2dxd and DO10/H-2bxd mice. Histogram depicts CD5 levels on CD4+ KJ126hi thymocytes. Bottom: Two-color (CD4 versus KJ126) analysis of lymph node cells from DO10/H-2dxd and DO10/H-2bxd mice. Large histogram depicts CD5 levels on CD4+ KJ126hi T cells. Small histograms show CD4 and KJ126-TCR levels on total CD4+ T cells. Numbers in boxes depict mean CD5 fluorescence for the transgenic TCRhi cells. (B) Comparison of CD5 levels on CD8+ T cells generated in P14 TCR transgenic mice expressing TCRs containing full-length (ζ-3 ITAM) or signaling defective (ζ-0 ITAM) ζ-chains Histograms depict Vα2, TCR-β, CD8, or CD5 staining on gated CD8+Vα2+ T cells (gates are shown in the two-color plots). Numbers in boxes depict mean CD5 fluorescence.
Figure 7 (A) Comparison of CD5 levels on CD4+ thymocytes and T cells from DO10 TCR transgenic mice generated in the H-2dxd and H-2bxd backgrounds. Top: Two-color (CD4 versus CD8) analysis of thymocytes from DO10/H-2dxd and DO10/H-2bxd mice. Histogram depicts CD5 levels on CD4+ KJ126hi thymocytes. Bottom: Two-color (CD4 versus KJ126) analysis of lymph node cells from DO10/H-2dxd and DO10/H-2bxd mice. Large histogram depicts CD5 levels on CD4+ KJ126hi T cells. Small histograms show CD4 and KJ126-TCR levels on total CD4+ T cells. Numbers in boxes depict mean CD5 fluorescence for the transgenic TCRhi cells. (B) Comparison of CD5 levels on CD8+ T cells generated in P14 TCR transgenic mice expressing TCRs containing full-length (ζ-3 ITAM) or signaling defective (ζ-0 ITAM) ζ-chains Histograms depict Vα2, TCR-β, CD8, or CD5 staining on gated CD8+Vα2+ T cells (gates are shown in the two-color plots). Numbers in boxes depict mean CD5 fluorescence.CC BY-NC-SA · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 50

  1. Ledbetter, 1980, T cell subsets defined by expression of Lyt-1,2,3 and Thy-1 antigens: two parameter immunofluorescence and cytotoxicity analysis with monoclonal antibodies modifies current views, J Exp Med, 152, 280, 10.1084/jem.152.2.280 · DOI
  2. Hayakawa, 1983, The “Ly-1 B” cell subpopulation in normal, immunodefective, and autoimmune mice, J Exp Med, 157, 202, 10.1084/jem.157.1.202 · DOI
  3. Fowlkes, 1985, Early T lymphocytes: differentiation in vivo of adult intrathymic precursor cells, J Exp Med, 162, 802, 10.1084/jem.162.3.802 · DOI
  4. Huang, 1987, Molecular cloning of Ly-1, a membrane glycoprotein of mouse T lymphocytes and a subset of B cells: molecular homology to its human counterpart Leu-1/T1 (CD5), Proc Natl Acad Sci USA, 84, 204, 10.1073/pnas.84.1.204 · DOI
  5. Van De Helde, 1991, The B-cell surface protein CD72/Lyb2 is the ligand for CD5, Nature, 351, 662, 10.1038/351662a0 · DOI
  6. Biancone, 1996, Identification of a novel inducible cell-surface ligand of CD5 on activated lymphocytes, J Exp Med, 184, 811, 10.1084/jem.184.3.811 · DOI
  7. Thomas, 1995, Of ITAMs and ITIMs: turning on and off the B cell antigen receptor, J Exp Med, 181, 1953, 10.1084/jem.181.6.1953 · DOI
  8. Davies, 1992, CD5 is phosphorylated on tyrosine after stimulation of the T-cell antigen receptor complex, Proc Natl Acad Sci USA, 89, 6368, 10.1073/pnas.89.14.6368 · DOI
  9. Beyers, 1992, Molecular associations between the T-lymphocyte antigen receptor complex and the surface antigens CD2, CD4, or CD8 and CD5, Proc Natl Acad Sci USA, 89, 2945, 10.1073/pnas.89.7.2945 · DOI
  10. Burgess, 1992, CD5 acts as a tyrosine kinase substrate within a receptor complex comprising T-cell receptor ζ chain/CD3 and protein-tyrosine kinases p56lck and p59fyn, Proc Natl Acad Sci USA, 89, 9311, 10.1073/pnas.89.19.9311 · DOI
  11. Pani, 1996, Signaling capacity of the T cell antigen receptor is negatively regulated by the PTP1C tyrosine phosphatase, J Exp Med, 184, 839, 10.1084/jem.184.3.839 · DOI
  12. Gary-Gouy, 1997, In vivo association of CD5 with tyrosine-phosphorylated Zap-70 and p21 phospho-ζ molecules in human CD3+thymocytes, J Immunol, 159, 3739, 10.4049/jimmunol.159.8.3739 · DOI
  13. Ceuppens, 1986, Monoclonal antibodies to the CD5 antigen can provide the necessary second signal for activation of isolated resting T cells by solid-phase-bound OKT3, J Immunol, 137, 1816, 10.4049/jimmunol.137.6.1816 · DOI
  14. Spertini, 1991, Induction of human T cell proliferation by a monoclonal antibody to CD5, J Immunol, 146, 47, 10.4049/jimmunol.146.1.47 · DOI
  15. Stanton, 1986, Anti-Ly-1 antibody induces interleukin 2 release from T cells, J Immunol, 136, 1734, 10.4049/jimmunol.136.5.1734 · DOI
  16. Tarakhovsky, 1995, A role for CD5 in TCR-mediated signal transduction and thymocyte selection, Science, 269, 535, 10.1126/science.7542801 · DOI
  17. Bikah, 1996, CD5-mediated negative regulation of antigen receptor-induced growth signals in B-1 B cells, Science, 274, 1906, 10.1126/science.274.5294.1906 · DOI
  18. Shinkai, 1992, Rag-2 deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement, Cell, 68, 855, 10.1016/0092-8674(92)90029-C · DOI · Paper page
  19. Zijlstra, 1989, Germ-line transmission of β2-microglobulin gene produced by homologous recombination in embryonic stem cells, Nature, 342, 435, 10.1038/342435a0 · DOI
  20. Grusby, 1991, Depletion of CD4+T cells in major histocompatibility complex class II-deficient mice, Science, 253, 1417, 10.1126/science.1910207 · DOI
  21. Grusby, 1993, Mice lacking major histocompatibility complex class I and class II molecules, Proc Natl Acad Sci USA, 90, 3913, 10.1073/pnas.90.9.3913 · DOI
  22. Molina, 1992, Profound block in thymocyte development in mice lacking p56lck, Nature, 357, 161, 10.1038/357161a0 · DOI
  23. Pircher, 1989, Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen, Nature, 342, 559, 10.1038/342559a0 · DOI
  24. Von Boehmer, 1990, Developmental biology of T cells in T cell receptor transgenic mice, Annu Rev Immunol, 8, 531, 10.1146/annurev.iy.08.040190.002531 · DOI
  25. Kaye, 1989, Selective development of CD4+T cells in transgenic mice expressing a class II MHC-restricted antigen receptor, Nature, 341, 746, 10.1038/341746a0 · DOI
  26. Murphy, 1990, Induction by antigen of intrathymic apoptosis of CD4+CD8+ TCRlothymocytes in vivo, Science, 250, 1720, 10.1126/science.2125367 · DOI
  27. Love, 1993, T cell development in mice that lack the ζ chain of the T cell antigen receptor complex, Science, 261, 918, 10.1126/science.7688481 · DOI
  28. Shores, 1994, Role of TCRζ chain in T cell development and selection, Science, 226, 1047, 10.1126/science.7526464 · DOI
  29. Borst, 1996, Composition and function of T-cell receptor and B-cell receptor complexes on precursor lymphocytes, Curr Opin Immunol, 8, 181, 10.1016/S0952-7915(96)80056-2 · DOI
  30. Punt, 1996, Lineage commitment in the thymus: only the most differentiated (TCRhibcl-2hi) subset of CD4+CD8+thymocytes has selectively terminated CD4 or CD8 synthesis, J Exp Med, 184, 2091, 10.1084/jem.184.6.2091 · DOI
  31. Godfrey, 1993, Control points in early T-cell development, Immunol Today, 14, 547, 10.1016/0167-5699(93)90186-O · DOI
  32. Hoffman, 1996, Productive T-cell receptor beta-chain rearrangement: coincident regulation of cell cycle and clonality during development in vivo, Genes Dev, 10, 948, 10.1101/gad.10.8.948 · DOI
  33. Levelt, 1993, Restoration of early thymocyte differentiation in T-cell receptor β-chain deficient mutant mice by transmembrane signaling through CD3ε, Proc Natl Acad Sci USA, 90, 11401, 10.1073/pnas.90.23.11401 · DOI
  34. Shinkai, 1993, Restoration of T cell development in RAG-2-deficient mice by functional TCR transgenes, Science, 259, 822, 10.1126/science.8430336 · DOI
  35. Wiest, 1995, The molecular chaperone calnexin is expressed on the surface of immature thymocytes in association with clonotype-independent CD3 complexes, EMBO (Eur Mol Biol Organ) J, 14, 3425, 10.1002/j.1460-2075.1995.tb07348.x · DOI
  36. Levelt, 1995, Regulation of thymocyte development through CD3: functional dissociation between p56lckand CD3ζ in early thymic selection, Immunity, 3, 215, 10.1016/1074-7613(95)90091-8 · DOI
  37. Kearse, 1995, Early molecular events induced by T cell receptor (TCR) signaling in immature CD4+CD3+thymocytes: increased synthesis of TCR-α protein is an early response to TCR signaling that compensates for TCR-α instability, improves TCR assembly, and parallels other indicators of positive selection, J Exp Med, 181, 193, 10.1084/jem.181.1.193 · DOI
  38. Sheard, 1996, Heterogeneous expression of recombination activating genes and surface CD5 in CD3low CD4+CD8+thymocytes, J Immunol, 43, 619
  39. Groves, 1997, TCR engagement of CD4+CD8+thymocytes in vitro induces early aspects of positive selection, but not apoptosis, J Immunol, 158, 65, 10.4049/jimmunol.158.1.65 · DOI
  40. Punt, 1994, Negative selection of CD4+CD8+thymocytes by T cell receptor–induced apoptosis requires a costimulatory signal that can be provided by CD28, J Exp Med, 179, 709, 10.1084/jem.179.2.709 · DOI
  41. Jameson, 1995, Positive selection of thymocytes, Annu Rev Immunol, 13, 93, 10.1146/annurev.iy.13.040195.000521 · DOI
  42. Matechak, 1996, MHC class II-specific T cells can develop in the CD8 lineage when CD4 is absent, Immunity, 4, 337, 10.1016/S1074-7613(00)80247-2 · DOI
  43. Liu, 1996, Thymocytes can become mature T cells without passing through the CD4+CD8+, double positive stage, J Exp Med, 184, 1619, 10.1084/jem.184.5.1619 · DOI
  44. I, 1996, Day 11 mouse fetal thymus: phenotype and search for the point of commitment, Differentiation, 61, 53, 10.1046/j.1432-0436.1996.6110053.x · DOI
  45. Suzuki, 1997, Commitment of immature CD4+CD8+thymocytes to the CD4 lineage requires CD3 signaling but does not require expression of clonotypic T cell receptor (TCR) chains, J Exp Med, 186, 17, 10.1084/jem.186.1.17 · DOI
  46. Malissen, 1996, Functions of TCR and pre-TCR subunits: lessons from gene ablation, Curr Opin Immunol, 8, 383, 10.1016/S0952-7915(96)80129-4 · DOI
  47. Groves, 1996, Fyn can partially substitute for Lck in T lymphocyte development, Immunity, 5, 417, 10.1016/S1074-7613(00)80498-7 · DOI
  48. Tarakhovsky, 1994, Lymphocyte populations and immune responses in CD5-deficient mice, Eur J Immunol, 24, 1678, 10.1002/eji.1830240733 · DOI
  49. Dutz, 1995, Distinct differentiative stages of CD4+CD8+thymocyte development defined by the lack of coreceptor binding in positive selection, J Immunol, 154, 2588, 10.4049/jimmunol.154.6.2588 · DOI
  50. Robey, 1994, Selective events in T cell development, Annu Rev Immunol, 12, 675, 10.1146/annurev.iy.12.040194.003331 · DOI

Cited by

See all 587

Metadata

Authors
Azzam, H. S., Grinberg, A., Lui, K., Shen, H., Shores, E. W., & Love, P. E.
Affiliations
From the *Laboratory of Mammalian Genes and Development, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892; and the ‡Division of Hematologic Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20892
Venue
The Journal of Experimental Medicine
Publisher
Rockefeller University Press
Published
1998-12-21
Volume
188
Issue
12
Pages
2301-2311
ISSN
  • 0022-1007
  • 1540-9538
DOI
10.1084/jem.188.12.2301
PMC
PMC2212429
Cited by
587
References
0
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: CD5 Expression Is Developmentally Regulated By T Cell Receptor (TCR) Signals and TCR Avidity. https://app.cochat.ai/papers/10.1084/jem.188.12.2301
The paper
Azzam, H. S., Grinberg, A., Lui, K., Shen, H., Shores, E. W., & Love, P. E. (1998). CD5 Expression Is Developmentally Regulated By T Cell Receptor (TCR) Signals and TCR Avidity. The Journal of Experimental Medicine. https://doi.org/10.1084/jem.188.12.2301